Sokast 10mg Tablet
BronchodilatorMontelukast the active ingredient in Sokast. Mountelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor.
Sokast (Montelukast) is indicated in adults and paediatric patients 6 months of age and older for the prophyaxis and chronic treatment of asthma including:
The prevention of day and night time symptoms.
The treatment of aspirin sensitive asthmatic patients.
The prevention of exercise induced bronchoconstriction.
Description
Montelukast the active ingredient in Sokast. Mountelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor.
Sokast (Montelukast) is indicated in adults and paediatric patients 6 months of age and older for the prophyaxis and chronic treatment of asthma including:
The prevention of day and night time symptoms.
The treatment of aspirin sensitive asthmatic patients.
The prevention of exercise induced bronchoconstriction.
Sokast (Montelukast) is inducted for the relief of symptoms of allergic rhinitis:
Seasonal allergic rhinitis in adults and paediatric patients 2 years of age and older.
Perennial allergic rhinitis in adults and paediatric patients 6 months of age and older.
